Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

Authors :: Yelena Y. Janjigian
Nikolaus Schultz
Maurizio Scaltriti
Jorge A. Carrasquillo
David B. Solit
Jason S. Lewis
Barry S. Taylor
Elisa de Stanchina
Michael F. Berger
Wolfgang A. Weber
David H. Ilson
Christine A. Iacobuzio-Donahue
Heiko Schöder
Neeta Pandit-Taskar
Steven M. Larson
Richard B. Lanman
Rebecca J. Nagy
Todd Hembrough
Yuan Tian
Fabiola Cecchi
Besnik Qeriqi
Marissa Mattar
Marinela Capanu
Mario E. Lacouture
Karen Brown
Robert A. Lefkowitz
David P. Kelsen
Mark Schattner
Efsevia Vakiani
Joanne Soong
Gouri J. Nanjangud
Nancy Bouvier
Christopher J. Fong
Helen Won
Yaelle Tuvy
Geoffrey Y. Ku
Pau Castel
Jaclyn F. Hechtman
Francisco Sanchez-Vega
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Additional results for dual probe EGFR and ERBB2 FISH from Patients 9, 30 and 32.

Tools